RLAY — Relay Therapeutics, Inc. stock price, charts and financials

QT63Relay Therapeutics, Inc.

Relay Therapeutics, Inc. (NASDAQ: RLAY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
19.54
+0.76+4.05%
OverviewShort InterestFilings
RLAYQT63Relay Therapeutics, Inc.·NASDAQ
19.54+4.05%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
May 21, 2026424B5Prospectus
May 21, 20268-KCurrent report
May 19, 2026424B5Prospectus
May 19, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20264Statement of changes in beneficial ownership
May 05, 202610-QQuarterly report
May 05, 20268-KCurrent report
#1 / 25 of 425
Page
▼
/ 17